Regulation of heart rate following genetic deletion of the ß1 adrenergic receptor in larval zebrafish
Authors:
Open Access
- 16 June 2022
- journal article
- research article
- Published by Wiley in Acta Physiologica
- Vol. 235 (4) , e13849
Abstract
Aim: Although zebrafish are gaining popularity as biomedical models of cardiovascular disease, our understanding of their cardiac control mechanisms is fragmentary. Our goal was to clarify the controversial role of the ß1‐adrenergic receptor (AR) in the regulation of heart rate in zebrafish.Methods: CRISPR‐Cas9 was used to delete the adrb1 gene in zebrafish allowing us to generate a stable adrb1−/− line. Larval heart rates were measured during pharmacological protocols and with exposure to hypercapnia. Expression of the five zebrafish adrb genes were measured in larval zebrafish hearts using qPCR.Results: Compared with genetically matched wild‐types (adrb1+/+), adrb1−/− larvae exhibited ~20 beats min−1 lower heart rate, measured from 2 to 21 days post‐fertilization (dpf). Nevertheless, adrb1−/− larvae exhibited preserved positive chronotropic responses to pharmacological treatment with AR agonists (adrenaline, noradrenaline, isoproterenol), which were blocked by propranolol (general ß‐AR antagonist). Regardless of genotype, larvae exhibited similar increases in heart rate in response to hypercapnia (1% CO2) at 5 dpf, but tachycardia was blunted in adrb1−/− larvae at 6 dpf. adrb1 gene expression was abolished in the hearts of adrb1−/− larvae, confirming successful knockout. While gene expression of adrb2a and adrb3a was unchanged, adrb2b and adrb3b mRNA levels increased in adrb1−/− larval hearts.Conclusion: Despite adrb1 contributing to the setting of resting heart rate in larvae, it is not strictly essential for zebrafish, as we generated a viable and breeding adrb1−/− line. The chronotropic effects of adrenergic stimulation persist in adrb1−/− zebrafish, likely due to the upregulation of other ß‐AR subtypes.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (RGPIN 2017‐05545)
- Novo Nordisk Fonden (NNF19OC0055842)
This publication has 63 references indexed in Scilit:
- Cardiac and Metabolic Physiology of Early Larval Zebrafish (Danio rerio) Reflects Parental Swimming StaminaFrontiers in Physiology, 2012
- Toward a General Model for the Evolutionary Dynamics of Gene DuplicatesGenome Biology and Evolution, 2011
- Loss of M2muscarinic receptor function inhibits development of hypoxic bradycardia and alters cardiac β-adrenergic sensitivity in larval zebrafish (Danio rerio)American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- Characterization of housekeeping genes in zebrafish: male-female differences and effects of tissue type, developmental stage and chemical treatmentBMC Molecular Biology, 2008
- What Is the Role of β-Adrenergic Signaling in Heart Failure?Circulation Research, 2003
- Estimating regression models with unknown break‐pointsStatistics in Medicine, 2003
- Zebrafish: A new model on the pharmaceutical catwalkBioEssays, 2003
- β‐Adrenergic and Muscarinic Cholinergic Receptor Densities in the Human Sinoatrial Node:Journal of Cardiovascular Electrophysiology, 1996
- Differentiation of Receptor Systems activated by Sympathomimetic AminesNature, 1967
- THE PHARMACOLOGICAL DIFFERENTIATION OF ADRENERGIC RECEPTORS*Annals of the New York Academy of Sciences, 1967